Comparison of VT Ablation Outcomes Using Remote MAGNETIC Navigation Versus Manual Approach in a Low LVEF Population

NATerminatedINTERVENTIONAL
Enrollment

182

Participants

Timeline

Start Date

January 31, 2016

Primary Completion Date

February 15, 2022

Study Completion Date

February 15, 2022

Conditions
Tachycardia, Ventricular
Interventions
DEVICE

catheter ablation using magnetic navigation

elimination of cardiac arrhythmias through heating and destroying heart tissue with faulty electrical pathways through the use of Stereotaxis's Niobe ES System with the NaviStar RMT ThermoCool catheter or other magnetically compatible catheters.

DEVICE

catheter ablation using manual navigation

elimination of cardiac arrhythmias through heating and destroying heart tissue with faulty electrical pathways through the use of the NaviStar ThermoCool catheter or other manually navigated catheters.

Trial Locations (16)

2145

Westmead Hospital, Westmead

8000

AZ Sint-Jan, Bruges

10065

Weill Cornell Medical, New York

15030

Na Homolce Hospital, Prague

30912

Augusta University, Augusta

32803

Florida Hospital, Orlando

60453

Advocate Christ Medical Center, Oak Lawn

60637

University of Chicago Medical Center, Chicago

66160

The University of Kansas Medical Center, Kansas City

78705

Texas Cardiac Arrhythmia Research Foundation, Austin

84107

Intermountain Heart Institute, Murray

Unknown

ZNA Middelheim, Antwerp

Rigshospitalet, Copenhagen

Chu De Nancy - Hôpitaux De Brabois, Nancy

Onze Lieve Vrouwe Gasthuis (OLVG), Amsterdam

Erasmus Medical Center, Rotterdam

Sponsors

Lead Sponsor

All Listed Sponsors
lead

Stereotaxis

INDUSTRY